| Authors: |
Neelima N; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK., Elrewey H; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tobruk University, Tobruk, Libya., Smarakan S; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK., Ruiz A; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK., Wahajuddin M; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK., Joshi G; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK; Department of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar, 246174 Dist. Garhwal, Uttarakhand, India., Jha V; Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford BD71DP, UK. Electronic address: v.jha2@bradford.ac.uk. |